Commonwealth Equity Services’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Commonwealth Equity Services’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,536	Closed	-$106K	–	4124
2024 Q2	$106K	Sell	2,536 -1	-0%	-$42	﹤0.01%	3803
2024 Q1	$115K	Buy	+2,537	New	+$116K	﹤0.01%	3769
2021 Q4	–	Sell	-2,407	Closed	-$213K	–	3685
2021 Q3	$213K	Buy	+2,407	New	+$226K	﹤0.01%	3226
2021 Q2	–	Sell	-5,769	Closed	-$518K	–	3549
2021 Q1	$518K	Buy	+5,769	New	+$569K	﹤0.01%	2307

Other funds holding GNOM

OCM

One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.11B AUM 20.67% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services's GNOM Position: Q3 2024 in Review

Commonwealth Equity Services sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q3 2024, closing a stake of 2,536 shares — an estimated $106K sold.

Commonwealth Equity Services first reported a position in GNOM in Q1 2021 and held it in 4 quarters. The position peaked at $518K in Q1 2021. 64 funds tracked by Wall St. Rank hold GNOM as of Q3 2024.

Commonwealth Equity Services reported no remaining Global X Genomics & Biotechnology ETF position as of Q3 2024 after selling out during the quarter.
Commonwealth Equity Services sold 2,536 Global X Genomics & Biotechnology ETF shares in Q3 2024, an estimated $106K.
Commonwealth Equity Services first reported a position in Global X Genomics & Biotechnology ETF in Q1 2021 and held it in 4 quarters.
Commonwealth Equity Services's Global X Genomics & Biotechnology ETF position peaked at $518K in Q1 2021.
64 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2024.

Based on Commonwealth Equity Services's 13F filing for Q3 2024, filed 18 Oct 2024.